{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:16:48Z","timestamp":1780449408114,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Epilepsy is a central nervous system disorder causing uncontrollable seizures. One-third of patients do not respond to current medications, necessitating new treatments. This study targeted epileptogenesis, the process leading to chronic epilepsy, using human mesenchymal stem cells (MSCs) in a rodent model. MSC transplantation can positively affect neurodegenerative diseases by modifying inflammation. Additionally, glial cell line-derived neurotrophic factor (GDNF) may counteract seizures and tissue damage. We transplanted na\u00efve immortalized human adipose-derived MSCs (Ctrl-MSCs) or GDNF-releasing MSCs (GDNF-MSCs, releasing 588.67\u2009\u00b1\u200920.14 pg\/ml\/24\u00a0h GDNF) into rat hippocampi after kainic acid-induced status epilepticus. Seizure progression was monitored for 5 weeks using video-EEG, behavioral assessments, and histological analysis. Both cell types influenced epileptogenesis. GDNF-MSCs delayed early-stage seizures, while Ctrl-MSCs reduced seizure frequency in later stages. Differences emerged in seizure development and cumulative seizure count, with Ctrl-MSCs showing significant seizure-attenuating effects. Behavioral differences were also noted: Ctrl-MSCs improved short-term memory and reduced anxiety, whereas GDNF-MSCs primarily reduced anxiety without significantly improving memory. This study highlights the therapeutic potential of MSCs, with or without GDNF, in modulating epileptogenesis, offering promising avenues for future clinical treatments.<\/jats:p>","DOI":"10.1007\/s00018-025-05853-z","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T12:48:41Z","timestamp":1755780521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modulation of epileptogenesis through transplantation of human mesenchymal stem cells with or without GDNF release"],"prefix":"10.1007","volume":"82","author":[{"given":"Eli\u0161ka","family":"Waloschkov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esbj\u00f6rn","family":"Melin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Baumlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Mart\u00ednez","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merab","family":"Kokaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8317-7976","authenticated-orcid":false,"given":"Marco","family":"Ledri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"9859","key":"5853_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJL Murray","year":"2012","unstructured":"Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2197\u20132223","journal-title":"Lancet"},{"key":"5853_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J et al (2017) Prevalence and incidence of epilepsy. Neurology 88:296\u2013303","journal-title":"Neurology"},{"issue":"4","key":"5853_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/107385840100700410","volume":"7","author":"JJ Engel","year":"2001","unstructured":"Engel JJ (2001) Mesial temporal lobe epilepsy: what have we learned? Neuroscientist 7(4):340\u2013352","journal-title":"Neuroscientist"},{"key":"5853_CR4","doi-asserted-by":"crossref","unstructured":"Leite JP, Garcia-Cairasco N, Cavalheiro EA (2002) New insights from the use of pilocarpine and Kainate models. Epilepsy Res 50(1\u20132):93\u2013103","DOI":"10.1016\/S0920-1211(02)00072-4"},{"key":"5853_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/pr.110.003046","volume":"62","author":"W L\u00f6scher","year":"2010","unstructured":"L\u00f6scher W, Brandt C, American Society for Pharmacology and Experimental Therapeutics (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668\u2013700","journal-title":"Pharmacol Rev"},{"issue":"1 SUPPL","key":"5853_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yebeh.2008.09.023","volume":"14","author":"A Pitk\u00e4nen","year":"2009","unstructured":"Pitk\u00e4nen A, Lukasiuk K (2009) Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14(1 SUPPL):16\u201325","journal-title":"Epilepsy Behav"},{"issue":"7","key":"5853_CR7","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","volume":"42","author":"W L\u00f6scher","year":"2017","unstructured":"L\u00f6scher W (2017) Animal models of seizures and epilepsy: past, present, and future role for the discovery of Antiseizure drugs. Neurochem Res 42(7):1873\u20131888","journal-title":"Neurochem Res"},{"issue":"1","key":"5853_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.expneurol.2012.04.011","volume":"236","author":"A Voulgari-Kokota","year":"2012","unstructured":"Voulgari-Kokota A, Fairless R, Karamita M, Kyrargyri V, Tseveleki V, Evangelidou M et al (2012) Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp Neurol 236(1):161\u2013170","journal-title":"Exp Neurol"},{"issue":"6","key":"5853_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1179\/1743132810Y.0000000018","volume":"33","author":"A Abdanipour","year":"2011","unstructured":"Abdanipour A, Tiraihi T, Mirnajafi-Zadeh J (2011) Improvement of the pilocarpine epilepsy model in rat using bone marrow stromal cell therapy. Neurol Res 33(6):625\u2013632","journal-title":"Neurol Res"},{"issue":"2\u20133","key":"5853_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eplepsyres.2009.01.002","volume":"84","author":"T Li","year":"2009","unstructured":"Li T, Ren G, Kaplan DL, Boison D (2009) Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis. Epilepsy Res 84(2\u20133):238\u2013241","journal-title":"Epilepsy Res"},{"key":"5853_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2013.07.020","volume":"1532","author":"Q Long","year":"2013","unstructured":"Long Q, Qiu B, Wang K, Yang J, Jia C, Xin W et al (2013) Genetically engineered bone marrow mesenchymal stem cells improve functional outcome in a rat model of epilepsy. Brain Res 1532:1\u201313","journal-title":"Brain Res"},{"key":"5853_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.eplepsyres.2018.02.008","volume":"141","author":"S Fukumura","year":"2018","unstructured":"Fukumura S, Sasaki M, Kataoka-Sasaki Y, Oka S, Nakazaki M, Nagahama H et al (2018) Intravenous infusion of mesenchymal stem cells reduces epileptogenesis in a rat model of status epilepticus. Epilepsy Res 141:56\u201363","journal-title":"Epilepsy Res"},{"issue":"04","key":"5853_CR13","first-page":"1","volume":"04","author":"B Tamura","year":"2014","unstructured":"Tamura B, Almeida D, Felizardo R, Olanda G, Bocca L, Pinhal N et al (2014) Convulsive seizure protection after hippocampal transplantation of mesenchymal cells from adipose tissue in mice. J Stem Cell Res Therapy 04(04):1\u20137","journal-title":"J Stem Cell Res Therapy"},{"key":"5853_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbi.2015.12.021","volume":"54","author":"PY Huang","year":"2016","unstructured":"Huang PY, Shih YH, Tseng YJ, Ko TL, Fu YS, Lin YY (2016) Xenograft of human umbilical mesenchymal stem cells from Wharton\u2019s jelly as a potential therapy for rat pilocarpine-induced epilepsy. Brain Behav Immun 54:45\u201358","journal-title":"Brain Behav Immun"},{"key":"5853_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127302","author":"A Toyoshima","year":"2015","unstructured":"Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F et al (2015) Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0127302","journal-title":"PLoS One"},{"issue":"1","key":"5853_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12031-009-9302-8","volume":"41","author":"Y Barhum","year":"2010","unstructured":"Barhum Y, Gai-Castro S, Bahat-Stromza M, Barzilay R, Melamed E, Offen D (2010) Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci 41(1):129\u2013137","journal-title":"J Mol Neurosci"},{"issue":"4","key":"5853_CR17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1073\/pnas.042678299","volume":"99","author":"CP Hofstetter","year":"2002","unstructured":"Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ et al (2002) Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99(4):2199\u20132204","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"5853_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5966\/sctm.2016-0071","volume":"6","author":"FG Teixeira","year":"2017","unstructured":"Teixeira FG, Carvalho MM, Panchalingam KM, Rodrigues AJ, Mendes-Pinheiro B, Anjo S et al (2017) Impact of the secretome of human mesenchymal stem cells on brain structure and animal behavior in a rat model of parkinson\u2019s disease. STEM CELLS Translational Med 6(2):634\u2013646","journal-title":"STEM CELLS Translational Med"},{"issue":"1","key":"5853_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","volume":"52","author":"DE Rodr\u00edguez-Fuentes","year":"2021","unstructured":"Rodr\u00edguez-Fuentes DE, Fern\u00e1ndez-Garza LE, Samia-Meza JA, Barrera-Barrera SA, Caplan AI, Barrera-Salda\u00f1a HA (2021) Mesenchymal stem cells current clinical applications: a systematic review. Arch Med Res 52(1):93\u2013101","journal-title":"Arch Med Res"},{"issue":"9","key":"5853_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang X, Ding Y, Zhang Y, Tse HF, Lian Q (2014) Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant 23(9):1045\u20131059","journal-title":"Cell Transplant"},{"issue":"1","key":"5853_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1634\/stemcells.2004-0236","volume":"24","author":"DG Phinney","year":"2006","unstructured":"Phinney DG, Hill K, Michelson C, DuTreil M, Hughes C, Humphries S et al (2006) Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy. Stem Cells 24(1):186\u2013198","journal-title":"Stem Cells"},{"issue":"11","key":"5853_CR22","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2014current views. Stem Cells 25(11):2896\u20132902","journal-title":"Stem Cells"},{"issue":"2","key":"5853_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cyto.2005.04.004","volume":"31","author":"HK Dong","year":"2005","unstructured":"Dong HK, Keon HY, Kyung SC, Choi J, Choi SY, Yang SE et al (2005) Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine 31(2):119\u2013126","journal-title":"Cytokine"},{"key":"5853_CR24","doi-asserted-by":"crossref","unstructured":"Simonato M, Tongiorgi E, Kokaia M (2006) Angels and demons: neurotrophic factors and epilepsy. Trends Pharmacol Sci 27(12):631\u20138","DOI":"10.1016\/j.tips.2006.10.002"},{"issue":"6","key":"5853_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/sj.mt.6300148","volume":"15","author":"I Kanter-Schlifke","year":"2007","unstructured":"Kanter-Schlifke I, Georgievska B, Kirik D, Kokaia M (2007) Seizure suppression by GDNF gene therapy in animal models of epilepsy. Mol Ther 15(6):1106\u20131113","journal-title":"Mol Ther"},{"issue":"2","key":"5853_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.expneurol.2008.12.021","volume":"216","author":"I Kanter-Schlifke","year":"2009","unstructured":"Kanter-Schlifke I, Fjord-Larsen L, Kusk P, \u00c4ngehagen M, Wahlberg L, Kokaia M (2009) GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus. Exp Neurol 216(2):413\u2013419","journal-title":"Exp Neurol"},{"issue":"3\u20134","key":"5853_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41434-018-0050-7","volume":"26","author":"A Nanobashvili","year":"2019","unstructured":"Nanobashvili A, Melin E, Emerich D, Torn\u00f8e J, Simonato M, Wahlberg L et al (2019) Unilateral ex vivo gene therapy by GDNF in epileptic rats. Gene Ther 26(3\u20134):65\u201374","journal-title":"Gene Ther"},{"issue":"11","key":"5853_CR28","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1523\/JNEUROSCI.0435-18.2018","volume":"39","author":"G Paolone","year":"2019","unstructured":"Paolone G, Falcicchia C, Lovisari F, Kokaia M, Bell WJ, Fradet T et al (2019) Long-Term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy. J Neuroscience: Official J Soc Neurosci 39(11):2144\u20132156","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"1","key":"5853_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1460-9568.2010.07272.x","volume":"32","author":"V Duveau","year":"2010","unstructured":"Duveau V, Fritschy JM (2010) PSA-NCAM-dependent GDNF signaling limits neurodegeneration and epileptogenesis in temporal lobe epilepsy. Eur J Neurosci 32(1):89\u201398","journal-title":"Eur J Neurosci"},{"issue":"3","key":"5853_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281\u2013294","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"5853_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nbd.2015.11.014","volume":"86","author":"L Nikitidou Ledri","year":"2016","unstructured":"Nikitidou Ledri L, Melin E, Christiansen SH, G\u00f8tzsche CR, Cifra A, Woldbye DPD et al (2016) Translational approach for gene therapy in epilepsy: model system and unilateral overexpression of neuropeptide Y and Y2 receptors. Neurobiol Dis 86:52\u201361","journal-title":"Neurobiol Dis"},{"issue":"47","key":"5853_CR32","doi-asserted-by":"publisher","first-page":"14932","DOI":"10.1523\/JNEUROSCI.2769-09.2009","volume":"29","author":"M Sasaki","year":"2009","unstructured":"Sasaki M, Radtke C, Tan AM, Zhao P, Hamada H, Houkin K et al (2009) Bdnf-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 29(47):14932\u201314941","journal-title":"J Neurosci"},{"issue":"12","key":"5853_CR33","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/jnr.22435","volume":"88","author":"A Glavaski-Joksimovic","year":"2010","unstructured":"Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC (2010) Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson\u2019s disease. J Neurosci Res 88(12):2669\u20132681","journal-title":"J Neurosci Res"},{"issue":"4","key":"5853_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10787-018-0456-2","volume":"26","author":"NA Salem","year":"2018","unstructured":"Salem NA, El-Shamarka M, Khadrawy Y, El-Shebiney S (2018) New prospects of mesenchymal stem cells for ameliorating temporal lobe epilepsy. Inflammopharmacology 26(4):963\u2013972","journal-title":"Inflammopharmacology"},{"key":"5853_CR35","doi-asserted-by":"crossref","unstructured":"Huicong K, Zheng X, Furong W, Zhouping T, Feng X, Qi H et al (2013) The imbalanced expression of adenosine receptors in an epilepsy model corrected using targeted mesenchymal stem cell transplantation. Mol Neurobiol 48(3):921\u201330","DOI":"10.1007\/s12035-013-8480-0"},{"issue":"2\u20133","key":"5853_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0920-1211(98)00092-8","volume":"34","author":"RM Arida","year":"1999","unstructured":"Arida RM, Scorza FA, De Araujo Peres C, Cavalheiro EA (1999) The course of untreated seizures in the pilocarpine model of epilepsy. Epilepsy Res 34(2\u20133):99\u2013107","journal-title":"Epilepsy Res"},{"issue":"2","key":"5853_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.expneurol.2007.03.008","volume":"205","author":"K Goffin","year":"2007","unstructured":"Goffin K, Nissinen J, Van Laere K, Pitk\u00e4nen A (2007) Cyclicity of spontaneous recurrent seizures in pilocarpine model of temporal lobe epilepsy in rat. Exp Neurol 205(2):501\u2013505","journal-title":"Exp Neurol"},{"issue":"2","key":"5853_CR38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.nbd.2010.07.015","volume":"40","author":"A Bortel","year":"2010","unstructured":"Bortel A, L\u00e9vesque M, Biagini G, Gotman J, Avoli M (2010) Convulsive status epilepticus duration as determinant for epileptogenesis and interictal discharge generation in the rat limbic system. Neurobiol Dis 40(2):478\u2013489","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5853_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.expneurol.2007.07.016","volume":"208","author":"G Ren","year":"2007","unstructured":"Ren G, Li T, Lan JQ, Wilz A, Simon RP, Boison D (2007) Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. Exp Neurol 208(1):26\u201337","journal-title":"Exp Neurol"},{"issue":"1","key":"5853_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49428-y","volume":"9","author":"M Das","year":"2019","unstructured":"Das M, Mayilsamy K, Tang X, Han JY, Foran E, Willing AE et al (2019) Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats. Sci Rep 9(1):1\u201313","journal-title":"Sci Rep"},{"key":"5853_CR41","doi-asserted-by":"crossref","unstructured":"Widner H, Brundin P (1988) Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res 472(3):287\u2013324","DOI":"10.1016\/0165-0173(88)90010-0"},{"issue":"7","key":"5853_CR42","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1523\/JNEUROSCI.0980-08.2009","volume":"29","author":"PA Williams","year":"2009","unstructured":"Williams PA, White AM, Clark S, Ferraro DJ, Swiercz W, Staley KJ et al (2009) Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J Neurosci 29(7):2103\u20132112","journal-title":"J Neurosci"},{"key":"5853_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.expneurol.2019.02.006","volume":"315","author":"MO Baud","year":"2019","unstructured":"Baud MO, Ghestem A, Benoliel JJ, Becker C, Bernard C (2019) Endogenous multidien rhythm of epilepsy in rats. Exp Neurol 315:82\u201387","journal-title":"Exp Neurol"},{"issue":"1","key":"5853_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12967-023-04695-2","volume":"21","author":"S Sandouka","year":"2023","unstructured":"Sandouka S, Singh PK, Saadi A, Taiwo RO, Sheeni Y, Zhang T, Deeb L, Guignet M, White SH, Shekh-Ahmad T (2023) Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy. J Transl Med 21(1):796","journal-title":"J Transl Med"},{"issue":"5","key":"5853_CR45","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/epi.17561","volume":"64","author":"AM Costa","year":"2023","unstructured":"Costa AM, Gol M, Lucchi C, Biagini G (2023) Antiepileptogenic effects of trilostane in the Kainic acid model of Temporal lobe epilepsy. Epilepsia 64(5):1376\u20131389","journal-title":"Epilepsia"},{"issue":"24","key":"5853_CR46","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.3390\/cells11244129","volume":"11","author":"MR Tesiye","year":"2022","unstructured":"Tesiye MR, Gol M, Fadardi MR, Kani SNM, Costa AM, Ghasemi-Kasman M, Biagini G (2022) Therapeutic potential of mesenchymal stem cells in the treatment of epilepsy and their interaction with Antiseizure medications. Cells 11(24):4129","journal-title":"Cells"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05853-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05853-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05853-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:40:56Z","timestamp":1757479256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05853-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5853"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05853-z","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments described in this work were conducted in agreement with the Swedish Animal Welfare Agency regulations and the EU Directive 2010\/63\/EU for animal experiments, and have been approved under the permission \u201cMechanisms of epilepsy and epileptogenesis: cell and gene therapy studies in rats and mice\u201d, by the local Malm\u00f6 and Lund ethical committee for animal research on 4 April 2020 (number 5.8.18-02998-2020). The study adheres to the ARRIVE guidelines for animal pre-clinical studies.The original source of the cell line (ATCC) has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. The hTERT-AT-MSCs (SCRC4000) cell line used in this study was obtained from ATCC under a Material Transfer Agreement (MTA) with Lund University. ATCC ensures that all human-derived materials it distributes comply with 45 CFR 46 and relevant ethical regulations. As part of its policy, ATCC requires depositors to confirm that all human tissue samples used to establish cell lines were collected under protocols approved by an Institutional Review Board (IRB), with prior informed consent from donors or their legally authorized representatives, and with appropriate confidentiality safeguards in place. Additionally, the Material Transfer Agreement (MTA) between ATCC and our institution explicitly states that the materials provided have been collected in compliance with all applicable ethical regulations, including donor consent and confidentiality protections. Further documentation is available in the ATCC Donor Policy Letter and the MTA Agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}